📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Feasibility of randomizing Danish citizens aged 65-79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial. (2022)

First Author: Johansen ND

Attributed to: RECOVERY/Phase 2 Therapeutic Trials Reconfiguration funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s40814-022-01044-w

PubMed Identifier: 35449028

Publication URI: http://europepmc.org/abstract/MED/35449028

Type: Journal Article/Review

Volume: 8

Parent Publication: Pilot and feasibility studies

Issue: 1

ISSN: 2055-5784